OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Parkinson disease-associated cognitive impairment
Dag Aarsland, Lucia Batzu, Glenda M. Halliday, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 754
Dag Aarsland, Lucia Batzu, Glenda M. Halliday, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 754
Showing 1-25 of 754 citing articles:
Exploring the Frontiers of Neuroimaging: A Review of Recent Advances in Understanding Brain Functioning and Disorders
Chiahui Yen, Chia-Li Lin, Ming‐Chang Chiang
Life (2023) Vol. 13, Iss. 7, pp. 1472-1472
Open Access | Times Cited: 109
Chiahui Yen, Chia-Li Lin, Ming‐Chang Chiang
Life (2023) Vol. 13, Iss. 7, pp. 1472-1472
Open Access | Times Cited: 109
From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration
Sheryar Afzal, Aimi Syamima Abdul Manap, Ali Attiq, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 104
Sheryar Afzal, Aimi Syamima Abdul Manap, Ali Attiq, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 104
Physical exercise for people with Parkinson’s disease: a systematic review and network meta-analysis
Moritz Ernst, Ann‐Kristin Folkerts, Romina Gollan, et al.
Cochrane library (2023) Vol. 2023, Iss. 5
Closed Access | Times Cited: 97
Moritz Ernst, Ann‐Kristin Folkerts, Romina Gollan, et al.
Cochrane library (2023) Vol. 2023, Iss. 5
Closed Access | Times Cited: 97
Clinical and imaging evidence of brain-first and body-first Parkinson's disease
Jacob Horsager, Karoline Knudsen, Michael Sommerauer
Neurobiology of Disease (2022) Vol. 164, pp. 105626-105626
Open Access | Times Cited: 95
Jacob Horsager, Karoline Knudsen, Michael Sommerauer
Neurobiology of Disease (2022) Vol. 164, pp. 105626-105626
Open Access | Times Cited: 95
Aleksandra A. Szwedo, Ingvild Dalen, Kenn Freddy Pedersen, et al.
Movement Disorders (2022) Vol. 37, Iss. 5, pp. 1016-1027
Open Access | Times Cited: 76
Association between age at onset of multimorbidity and incidence of dementia: 30 year follow-up in Whitehall II prospective cohort study
Céline Ben Hassen, Aurore Fayossé, Benjamin Landré, et al.
BMJ (2022), pp. e068005-e068005
Open Access | Times Cited: 71
Céline Ben Hassen, Aurore Fayossé, Benjamin Landré, et al.
BMJ (2022), pp. e068005-e068005
Open Access | Times Cited: 71
The Role of Glymphatic System in Alzheimer’s and Parkinson’s Disease Pathogenesis
Francesca R. Buccellato, Marianna D’Anca, María Serpente, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2261-2261
Open Access | Times Cited: 68
Francesca R. Buccellato, Marianna D’Anca, María Serpente, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2261-2261
Open Access | Times Cited: 68
Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study
Dong Ji, Wen-Zhu Chen, Lei Zhang, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 46
Dong Ji, Wen-Zhu Chen, Lei Zhang, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 46
Physical exercise for people with Parkinson’s disease: a systematic review and network meta-analysis
Moritz Ernst, Ann‐Kristin Folkerts, Romina Gollan, et al.
Cochrane library (2024) Vol. 2024, Iss. 4
Closed Access | Times Cited: 40
Moritz Ernst, Ann‐Kristin Folkerts, Romina Gollan, et al.
Cochrane library (2024) Vol. 2024, Iss. 4
Closed Access | Times Cited: 40
Dementia Prevention and Treatment
David B. Reuben, Sarah Kremen, Donovan T. Maust
JAMA Internal Medicine (2024) Vol. 184, Iss. 5, pp. 563-563
Open Access | Times Cited: 35
David B. Reuben, Sarah Kremen, Donovan T. Maust
JAMA Internal Medicine (2024) Vol. 184, Iss. 5, pp. 563-563
Open Access | Times Cited: 35
Significance of chitinase-3-like protein 1 in the pathogenesis of inflammatory diseases and cancer
Ji Eun Yu, In Jun Yeo, Sang‐Bae Han, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 1, pp. 1-18
Open Access | Times Cited: 30
Ji Eun Yu, In Jun Yeo, Sang‐Bae Han, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 1, pp. 1-18
Open Access | Times Cited: 30
Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology
Thomas Goralski, Lindsay Meyerdirk, Libby Breton, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 27
Thomas Goralski, Lindsay Meyerdirk, Libby Breton, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 27
Updated MDSGene review on the clinical and genetic spectrum of LRRK2 variants in Parkinson´s disease
Cleusa Adriane Menegassi Bianchi Krüger, Shen‐Yang Lim, Alissa Buhrmann, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Cleusa Adriane Menegassi Bianchi Krüger, Shen‐Yang Lim, Alissa Buhrmann, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Escherichia Coli K1-colibactin meningitis induces microglial NLRP3/IL-18 exacerbating H3K4me3-synucleinopathy in human inflammatory gut-brain axis
Van Thi Ai Tran, Xiaohui Zhu, Ariunzaya Jamsranjav, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Van Thi Ai Tran, Xiaohui Zhu, Ariunzaya Jamsranjav, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Mitophagy in neurological disorders
Lijun Zhang, Lei Dai, Deyuan Li
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 83
Lijun Zhang, Lei Dai, Deyuan Li
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 83
Allicin, an Antioxidant and Neuroprotective Agent, Ameliorates Cognitive Impairment
Muhammad Shahid Nadeem, Imran Kazmi, Inam Ullah, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 87-87
Open Access | Times Cited: 73
Muhammad Shahid Nadeem, Imran Kazmi, Inam Ullah, et al.
Antioxidants (2021) Vol. 11, Iss. 1, pp. 87-87
Open Access | Times Cited: 73
Preventing Parkinson’s Disease: An Environmental Agenda
Briana R. De Miranda, Samuel M. Goldman, Gary W. Miller, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 1, pp. 45-68
Open Access | Times Cited: 63
Briana R. De Miranda, Samuel M. Goldman, Gary W. Miller, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 1, pp. 45-68
Open Access | Times Cited: 63
Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update
Noha Gouda, Ahmed Elkamhawy, Jungsook Cho
Biomedicines (2022) Vol. 10, Iss. 2, pp. 371-371
Open Access | Times Cited: 56
Noha Gouda, Ahmed Elkamhawy, Jungsook Cho
Biomedicines (2022) Vol. 10, Iss. 2, pp. 371-371
Open Access | Times Cited: 56
Functional brain networks in the evaluation of patients with neurodegenerative disorders
Matej Perovnik, Tomaž Rus, Katharina A. Schindlbeck, et al.
Nature Reviews Neurology (2022) Vol. 19, Iss. 2, pp. 73-90
Closed Access | Times Cited: 48
Matej Perovnik, Tomaž Rus, Katharina A. Schindlbeck, et al.
Nature Reviews Neurology (2022) Vol. 19, Iss. 2, pp. 73-90
Closed Access | Times Cited: 48
Interplay between aging and other factors of the pathogenesis of age-related macular degeneration
Janusz Błasiak, Piotr Sobczuk, Elżbieta Pawłowska, et al.
Ageing Research Reviews (2022) Vol. 81, pp. 101735-101735
Open Access | Times Cited: 42
Janusz Błasiak, Piotr Sobczuk, Elżbieta Pawłowska, et al.
Ageing Research Reviews (2022) Vol. 81, pp. 101735-101735
Open Access | Times Cited: 42
Mitochondrial Sirtuins in Parkinson’s Disease
Ling He, Jihong Wang, Yazhi Yang, et al.
Neurochemical Research (2022) Vol. 47, Iss. 6, pp. 1491-1502
Closed Access | Times Cited: 40
Ling He, Jihong Wang, Yazhi Yang, et al.
Neurochemical Research (2022) Vol. 47, Iss. 6, pp. 1491-1502
Closed Access | Times Cited: 40
GSK-3β: An exuberating neuroinflammatory mediator in Parkinson's disease
Sabiya Samim Khan, Sushmita Janrao, Saurabh Srivastava, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115496-115496
Open Access | Times Cited: 38
Sabiya Samim Khan, Sushmita Janrao, Saurabh Srivastava, et al.
Biochemical Pharmacology (2023) Vol. 210, pp. 115496-115496
Open Access | Times Cited: 38
The noradrenergic subtype of Parkinson disease: from animal models to clinical practice
К. Ray Chaudhuri, Valentina Leta, Kirsty Bannister, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 6, pp. 333-345
Closed Access | Times Cited: 38
К. Ray Chaudhuri, Valentina Leta, Kirsty Bannister, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 6, pp. 333-345
Closed Access | Times Cited: 38
White matter changes in Parkinson’s disease
Kai Yang, Zhengqi Wu, Jie Long, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Kai Yang, Zhengqi Wu, Jie Long, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Deficient chaperone-mediated autophagy facilitates LPS-induced microglial activation via regulation of the p300/NF-κB/NLRP3 pathway
Wu Jin, Yingying Han, Hao Xu, et al.
Science Advances (2023) Vol. 9, Iss. 40
Open Access | Times Cited: 33
Wu Jin, Yingying Han, Hao Xu, et al.
Science Advances (2023) Vol. 9, Iss. 40
Open Access | Times Cited: 33
